Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response

Clinical trial NCT00640250 · COMPLETED

Trial details

NCT number: NCT00640250
Sponsor: Allerderm
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Contact Dermatitis

Start date: 2008-04-01
Primary completion: 2009-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.